Plachouri, Kerasia-Maria; Georgiou, Sophia
Acta Dermatovenerologica Croatica Vol. 28, No. 3, 2020
Apremilast is an oral small-molecule phosphodiesterase 4 inhibitor with a multilevel immunomodulating mechanism of action. It has received approval in many countries for the use in moderate-tosevere plaque psoriasis and active psoriatic arthritis in adults. Herein, we review the literature concerning the use of apremilast in dermatology, with a focus on both the on- and the off-label uses of this medication in dermatologic conditions. This paper is a systematic overview of all the reported uses of apremilast in dermatology described in t...
Hrčak ID: 281294